Synergistic Endometrial Ablation System

Publication ID: 24-11857248_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Endometrial Ablation System,” Published Technical Disclosure No. 24-11857248_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857248_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,248.

Summary of the Inventive Concept

The present inventive concept integrates radio frequency-based endometrial ablation technology with advanced technologies such as machine learning, blockchain, IoT, and nanomaterials to create a more efficient, personalized, and secure system for treating menorrhagia.

Background and Problem Solved

The original patent disclosed a radio frequency-based endometrial ablation system for treating menorrhagia. However, the system had limitations in terms of optimizing treatment parameters, securing patient data, and enhancing tissue detection. The present inventive concept addresses these limitations by incorporating synergistic combinations of distinct technologies to create a more advanced and effective system.

Detailed Description of the Inventive Concept

The synergistic endometrial ablation system comprises a radio frequency-based ablation device, a machine learning module for predicting optimal ablation parameters based on patient-specific data, a blockchain-based data management system for securing and sharing patient data and treatment outcomes, an IoT-enabled sensor array for real-time monitoring of treatment parameters, and nanomaterial-enhanced tissue sensing for enhanced tissue detection. The AI-driven simulation platform generates customized treatment plans based on patient-specific anatomy and physiology. The system enables real-time monitoring, personalized treatment planning, and secure data management, thereby improving treatment outcomes and patient satisfaction.

Novelty and Inventive Step

The novel and non-obvious aspects of the present inventive concept lie in the integration of advanced technologies with radio frequency-based endometrial ablation technology to create a more efficient, personalized, and secure system. The combination of machine learning, blockchain, IoT, and nanomaterials with radio frequency ablation technology is unprecedented and provides a significant improvement over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the synergistic endometrial ablation system may include variations in the type of advanced technologies used, such as using different machine learning algorithms or incorporating other sensing modalities. Additionally, the system may be adapted for use in other medical applications, such as cancer treatment or cosmetic procedures.

Potential Commercial Applications and Market

The synergistic endometrial ablation system has significant commercial potential in the medical device industry, particularly in the women's health segment. The system's ability to provide personalized treatment plans, real-time monitoring, and secure data management makes it an attractive solution for healthcare providers and patients. The market for endometrial ablation devices is growing, and the present inventive concept is poised to capture a significant share of this market.

CPC Classifications

SectionClassGroup
A A61 A61B18/1485
A A61 A61B5/1076
A A61 A61B18/042
A A61 A61B2018/0022
A A61 A61B2018/00214
A A61 A61B2018/00559
A A61 A61B2018/00577
A A61 A61B2018/00666
A A61 A61B2018/147
A A61 A61B2090/064
A A61 A61B2218/008

Field of Art

Medical device technologies for minimally invasive surgical interventions, specifically electrosurgical systems for endometrial ablation, encompassing radiofrequency energy delivery, medical sensing technologies, and advanced medical informatics

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in electrosurgical technologies, advanced sensing systems, data analytics, and medical device integration, holding advanced degrees in bioengineering or medical technology with 5-10 years of practical experience

Obviousness Rationale

A PHOSITA would recognize that integrating advanced digital technologies like machine learning, IoT, and blockchain with existing radiofrequency ablation systems represents a predictable technological evolution. The source patent's foundational radiofrequency ablation methodology provides a clear technical framework for incorporating emerging digital health technologies. The proposed variations represent logical extensions of existing medical device innovation strategies focused on personalization, data security, and enhanced treatment precision.

Obvious Combinations & Variations

Source Patent Element
Expandable frame for uterine treatment member configured for energy delivery
PTD Variation
Adding IoT-enabled sensor array for real-time monitoring of treatment parameters
Obviousness Reasoning
Integrating sensor technologies into medical devices is a known technique for improving procedural monitoring and safety, representing a predictable application of existing technological capabilities
Source Patent Element
Electrosurgical system for treating uterine tissue
PTD Variation
Incorporating machine learning module for predicting optimal ablation parameters
Obviousness Reasoning
Applying machine learning to medical device optimization is a well-established approach for personalizing treatment protocols, representing a standard design choice in contemporary medical technology
Source Patent Element
Radio frequency current applied to endometrial tissue
PTD Variation
Implementing blockchain-based data management for securing patient treatment records
Obviousness Reasoning
Enhancing medical data security through blockchain is a recognized technological trend in healthcare informatics, representing a logical extension of existing data management practices
Source Patent Element
Capacitively coupled current delivery system
PTD Variation
Integrating nanomaterial-enhanced tissue sensing for improved detection specificity
Obviousness Reasoning
Utilizing advanced materials to enhance medical sensing capabilities is a predictable technological progression in medical device design, representing an incremental improvement in existing technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857248 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed synergistic endometrial ablation system variations obvious and non-patentable. The integration of machine learning, blockchain, IoT, and nanomaterial technologies with established radiofrequency ablation methodologies represents a predictable technological evolution that would be readily conceived by a skilled practitioner in medical device engineering.

Original Patent Information

Patent NumberUS 11,857,248
TitleMethods and systems for endometrial ablation utilizing radio frequency
Assignee(s)MINERVA SURGICAL, INC.